Lack of efficacy of aprotinin over tranexamic acid in type A aortic dissection repair.
Bryan ReidyDaniel AstonDaniel SitaranjanIbrahim Talal FazminMartin MuirJason AliRavi De SilvaFlorian FalterPublished in: Transfusion (2024)
Aprotinin did not reduce the risk of bleeding or transfusion requirements in patients undergoing repair of type A aortic dissections. Efficacy of aprotinin may vary depending on the type of surgery performed and the underlying pathology.